ALTO-100

N/A

Report date: 2022/11/13 11:45:20
NME

Base Information

Drug NameALTO-100
Drug Alias NameALTO-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBrain-derived neurotrophic factor modulators
TargetsBrain-derived neurotrophic factor
Therapy Area/IndicationsBipolar II DisorderBipolar I DisorderStress Disorders, Post-Traumatic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlto Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlto Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsBipolar II DisorderBipolar I DisorderStress Disorders, Post-Traumatic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A